OmniBiome believes that through the creation of

multiple walls of patent applications covering the space of pregnancy immunology, it will possess sufficient freedom to operate in its product development, as well as generate possible licensing revenues from others seeking to enter the space.

OmniBiome is focused on the utility of vaccines

and various agents to alter pathological conditions in the maternal immune system.